Oncolytics reports HPV immune activity data for pelareorep in anal cancerNov 4Clinical readoutOncolytics Biotechpelareorep
Oncolytics reports durability and survival data for pelareorep in anal cancerOct 27Regulatory decisionOncolytics Biotechpelareorep
Oncolytics reports faster enrollment in REO 033 colorectal cancer studyOct 1Trial updateCoherus Oncology, Inc.Oncolytics BiotechUpdated
Oncolytics gets FDA feedback on pivotal path for pelareorep in colorectal cancerAug 18Regulatory decisionOncolytics Biotechpelareorep
Oncolytics wins FDA Fast Track for pelareorep in second-line anal cancerJul 20Regulatory milestoneOncolytics Biotechpelareorep